Journal of Hypertension
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
IMPACT OF SEASONAL BLOOD PRESSURE CHANGES ON VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY
2023
-
CONTROL OF HYPERTENSION BY ETHNICS IN COLOMBIA, A SECONDARY ANALYSIS OF COLOMBIA PURE STUDY
2021
-
ETHNIC DIFFERENCES IN THE ASSOCIATION BETWEEN HANDGRIP STRENGTH AND THE PREVALENCE OF HYPERTENSION
2021
-
A12153 Quality of abstracts of pilot trials in heart failure
2018
-
A15374 Genetic Variant of Human Cholesterol Ester Transfer Protein (CETP) Raises HDL levels and Is Associated with Increased Risk for Large Vessel and Small Vessel Stroke in Chinese Patients
2018
-
ISH NIA PS 03-07 An assessment of the prevalence, detection, treatment and control of hypertension in HIV infected patients receiving care across public HIV care facilities in the Western Cape Province of South Africa
2016
-
SY 09-2 SALT INTAKE
2016
-
[OP.LB01.01] CARDIOVASCULAR RISK IN RELATION TO ACHIEVED AUTOMATED BLOOD PRESSURE IN CLINICAL PRACTICE
2016
-
[PP.26.05] BLOOD PRESSURE LOWERING IN INTERMEDIATE RISK PEOPLE WITHOUT VASCULAR DISEASE
2016
-
[PP.29.07] WORLDWIDE PREVALENCE OF METABOLIC SYNDROME IN PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION
2016
-
CHANGES IN ALBUMINURIA PREDICT MORTALITY AND MORBIDITY IN PATIENTS WITH VASCULAR DISEASE: PS.3.04
2010
-
IMPROVING CARDIOVASCULAR HEALTH AT THE POPULATION LEVEL: A 39 COMMUNITY CLUSTER-RANDOMISED TRIAL OF THE CARDIOVASCULAR HEALTH AWARENESS PROGRAM (CHAP): PS.3.03
2010
-
A FUNCTIONAL VARIANT RS1048990 IN PSMA6 IS ASSOCIATED WITH SUSCEPTIBILITY TO MYOCARDIAL INFARCTION IN A CHINESE POPULATION
2009
-
EFFECT OF COMBINATIONS OF ANTIHYPERTENSIVE DRUGS IN A POLYPILL (POLYCAP) ON BLOOD PRESSURE LOWERING, IN INDIVIDUALS WITHOUT CARDIOVASCULAR DISEASE
2009
-
EFFECTS OF RAMIPRIL, TELMISARTAN AND THEIR COMBINATION ON AMBULATORY BLOOD PRESSURE IN AN ONTARGET SUBSTUDY
2009
-
EFFECTS OF TELMISARTAN, RAMIPRIL AND THEIR COMBINATION ON LEFT VENTRICULAR HYPERTROPHY IN INDIVIDUALS AT HIGH VASCULAR RISK
2009
-
RENAL OUTCOMES IN THE TRANSCEND STUDY COMPARING TELMISARTAN TO PLACEBO IN PEOPLE WITH ESTABLISHED CARDIOVASCULAR DISEASE OR COMPLICATED DIABETES
2009
-
SAFETY AND EFFICACY OF AGGRESSIVE BLOOD PRESSURE LOWERING AMONG PATIENTS WITH DIABETES: SUBGROUP ANALYSES FROM THE ONTARGET TRIAL
2009
-
Effectiveness of a trandolapril-based treatment regimen in subjects with isolated systolic hypertension - a TRAIL subanalysis
2008
-
Risk factors associated with myocardial infarction in China: The INTERHEART China
2008
-
Community outreach heart health risk reduction trial (COHRT): Outcome for hypertensive subjects at high CVD risk
2006
-
LV structure in Asians and non-Asians with cardiovascular disease: Results from the ontarget cardiac MRI sub-study
2006
-
Perivascular adipose tissue promotes vessel constriction to perivascular nerve activation
2006
-
Beneficial effects of ramipril on cardiovascular events in high-risk patients >= 70 years: A subgroup analysis of the HOPE study
2006
-
TRAIL - the effectiveness of trandolapril based treatment regimen in reaching blood pressure goals: An observational study
2006
-
Weight loss and the renin-angiotensin-aldosterone system
2005
-
HYPERTENSION IS DIFFICULT TO NORMALIZE IN RENAL TRANSPLANT PATIENTS
2004
-
Three-dimensional image reconstruction of medullary blood supply in normotensive volume expanded rats
2000
-
Apoptosis in the muscular arteries from young spontaneously hypertensive rats
1998
-
Hyperplasia of medial smooth muscle cells is not responsible for vascular hypertrophy in hypertension
1998
-
The role of endothelium in flow-induced relaxation response of mesenteric arteries from hypertensive rats
1998
-
A preliminary study of non-invasive twenty-four-hour ambulatory blood pressure monitoring in normal and abnormal pregnancy
1991
-
Impact of hypertension on mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty: insights from the international multicenter ISACS-STEMI registry.
2024
-
Impact of seasonal blood pressure changes on visit-to-visit blood pressure variability and related cardiovascular outcomes.
42:1269-1281.
2024
-
Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension.
42:23-49.
2024
-
The use of loop diuretics in the context of hypertensive disorders of pregnancy: a systematic review and meta-analysis.
41:17-26.
2023
-
The Blood Pressure Lowering Treatment Trialists’ Collaboration: methodological clarifications of recent reports.
40:847-852.
2022
-
Measuring sodium intake: research and clinical applications.
39:2344-2352.
2021
-
Blood pressure in adults with cerebral palsy: a systematic review and meta-analysis of individual participant data.
39:1942-1955.
2021
-
Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke.
39:1602-1610.
2021
-
Reply.
39:1467-1469.
2021
-
Associations of household solid fuel for heating and cooking with hypertension in Chinese adults.
39:667-676.
2021
-
Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk.
39:766-774.
2021
-
Associations of estimated 24-h urinary sodium excretion with mortality and cardiovascular events in Chinese adults: a prospective cohort study.
39:484-493.
2021
-
Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials.
38:2050-2058.
2020
-
Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials..
38:2050-2058.
2020
-
Prevalence, awareness, treatment and control of hypertension in rural and urban communities in Latin American countries.
37:1813-1821.
2019
-
Increased blood pressure is associated with increased carotid artery intima–media thickness in children with repaired coarctation of the aorta.
37:1689-1698.
2019
-
Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean.
37:16-23.
2019
-
Whole blood omega-3 fatty acid concentrations are inversely associated with blood pressure in young, healthy adults.
36:1548-1554.
2018
-
Risk of stroke and coronary heart disease among various levels of blood pressure in diabetic and nondiabetic Chinese patients.
36:93-100.
2018
-
Practical and valid approaches in quantifying sodium intake in population studies.
35:2168-2170.
2017
-
Prevalence, awareness, treatment and control of hypertension in four Middle East countries.
35:1457-1464.
2017
-
Does spironolactone reduce the risk of urinary tract cancers in hypertensive patients?.
35:36-38.
2017
-
Social disparities explain differences in hypertension prevalence, detection and control in Colombia.
34:2344-2352.
2016
-
[OP.2B.09] PATIENTS WITH ADVANCED KIDNEY DISEASE AND NEPHROANGIOSCLEROSIS MIGHT NOT BENEFIT OF STRICT BLOOD PRESSURE CONTROL.
34:e21.
2016
-
Endoplasmic reticulum stress inhibition reduces hypertension through the preservation of resistance blood vessel structure and function.
34:1556-1569.
2016
-
Does the association between birth weight and blood pressure increase with age? A longitudinal study in young adults.
34:1062-1067.
2016
-
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT.
34:393-396.
2016
-
Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China.
34:39-46.
2016
-
[pp. 26.02] Free Versus Fixed Combination Antihypertensive Therapy For Essential Arterial Hypertension: A Systematic Review And Meta-analysis.
34:e273-e274.
2016
-
Response to ‘Estimation of sodium excretion should be made as simple as possible, but not simpler.
33:887-890.
2015
-
Effect of green tea supplementation on blood pressure among overweight and obese adults.
33:243-254.
2015
-
Reply to both letters.
32:2501-2503.
2014
-
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient.
32:1888-1897.
2014
-
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline.
32:1741-1750.
2014
-
Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24-h measures in 11 countries (vol 32, pg 1005, 2014).
32:1915-1915.
2014
-
Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk.
32:1334-1341.
2014
-
Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24-h measures in 11 countries.
32:1005-1015.
2014
-
European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring.
31:1731-1768.
2013
-
Angiotensin receptor blocker therapy and risk of cancer.
31:1532-1534.
2013
-
Hypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in Uganda.
31:1372-1378.
2013
-
Dual inhibition of the renin–angiotensin system in high-risk diabetes and risk for stroke and other outcomes.
31:414-421.
2013
-
Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies.
30:1004-1014.
2012
-
AMP-activated protein kinase activator AICAR acutely lowers blood pressure and relaxes isolated resistance arteries of hypertensive rats.
30:725-733.
2012
-
Is there an optimal combination of antihypertensives for preventing cardiovascular events?.
29:1483-1485.
2011
-
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals.
29:623-635.
2011
-
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study.
27:1360-1369.
2009
-
Endothelium-dependent relaxation factor released by perivascular adipose tissue.
27:782-790.
2009
-
Effects of hyperglycemia on the modulation of vascular function by perivascular adipose tissue.
27:118-131.
2009
-
Association of renin–angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study.
26:1780-1786.
2008
-
Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis.
26:1290-1299.
2008
-
Configuration of the microcirculation in pre-eclampsia: possible role of the venular system.
25:2512-2512.
2007
-
Configuration of the microcirculation in pre-eclampsia: possible role of the venular system.
25:1665-1670.
2007
-
Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system.
25:951-958.
2007
-
Changes in endothelium-derived hyperpolarizing factor and myogenic response in rats with chronic renal failure and their association with hypertension.
24:2153-2155.
2006
-
Initial data supporting the design of the Candesartan in Heart failure — Assessment of Reduction in Mortality and morbidity (CHARM) programme.
24:S9-S13.
2006
-
New evidence on the importance of the renin???angiotensin system in the treatment of higher-risk patients with hypertension.
21:1599-1608.
2003
-
The vascular amplifier and persisting resisters.
21:643-645.
2003
-
The vascular amplifier and persisting resisters.
21:643-645.
2003
-
Correspondence.
20:2522-2524.
2002
-
High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.
19:2271-2277.
2001
-
Apoptosis in the muscular arteries from young spontaneously hypertensive rats.
17:1413-1419.
1999
-
Cross-over study comparing effects of treatment with an angiotensin converting enzyme inhibitor and an angiotensin II type 1 receptor antagonist on cardiovascular changes in hypertension.
16:477-486.
1998
-
Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration..
16:127-137.
1998
-
Letter.
15:333-334.
1997
-
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension..
15:105-115.
1997
-
Perindopril treatment in the prevention of stroke in experimental animals.
14:S29???34-S29???34.
1996
-
Alterations in beta-adrenoceptors and polyploidy in cultured aortic smooth muscle cells from different age groups of spontaneously hypertensive rats and Wistar-Kyoto rats.
13:507-515.
1995
-
Perindopril treatment prolonged the lifespan of spontaneously hypertensive rats.
13:471-471.
1995
-
Arterial hypertrophy and pressor responsiveness during development of hypertension in spontaneously hypertensive rats.
12:23???32-23???32.
1994
-
Effects of the arterial vasodilator minoxidil on cardiovascular structure and sympathetic activity in spontaneously hypertensive rats.
11:1337-1345.
1993
-
Primary and secondary prevention of myocardial infarction and strokes.
11:S61???S74-S61???S74.
1993
-
Morphometric study of cerebral arteries from spontaneously hypertensive and stroke-prone spontaneously hypertensive rats.
10:1183-1190.
1992
-
Home blood pressure-measuring devices: A comparative study of accuracy.
7:133???142-133???142.
1989
-
High Resolution23Na-Nuclear Magnetic Resonance Study of Stroke-Prone Spontaneously Hypertensive Rat Erythrocytes.
5:359-366.
1987
-
DETERMINANTS OF PHYSICIANS COMPETENCE IN THE MANAGEMENT OF HYPERTENSION.
4:S367-S369.
1986
-
L-prolyl-L-leucyl-glycinamide analogues--a new class of peptide antihypertensives..
4:S106-S108.
1986
-
RELATIONSHIP BETWEEN SYMPATHETIC INNERVATION, VASCULAR CHANGES AND HYPERTENSION IN THE SPONTANEOUSLY HYPERTENSIVE RAT.
4:S81-S83.
1986
-
VASCULAR ELASTASE-LIKE ACTIVITIES IN RATS - RELATION TO HYPERTENSION.
4:S97-S99.
1986
-
Hypertension Control in Two Canadian Communities: Evidence For Better Treatment and Overlabelling.
4:369-374.
1986
-
Subcellular Membrane Properties in Vascular and Non-Vascular Smooth Muscles of Dahl Hypertensive Rats.
4:49-55.
1986
-
Contractile Responses of Vasa Deferentia from Rats with Genetic and Experimental Hypertension.
2:631-638.
1984
-
Failure of Weight Reduction to Reduce Mildly Elevated Blood Pressure: A Randomized Trial.
2:535-539.
1984
-
Membrane Abnormalities Occur in Vascular Smooth Muscle but not in Non-vascular Smooth Muscle from Rats with Deoxycorticosterone-salt Induced Hypertension.
1:257-265.
1983
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)